Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

EURECA project: Final look at Architecture, Standards and Integration

Published: 5 Aug 2015

Views: 1139

Rating:

Save

Kristof De Schepper - Custodix, Sint-Martens-Latem, Belgium

Kristof De Schepper discusses Work Package 2, its achievement aims and whether or not it has met those goals now that the project has come to an end. He also discusses how developments from this WP will be able to help European clinicians.

The goal of EURECA (Enabling information re-Use by linking clinical REsearch and Care) is to enable seamless, secure, scalable and consistent linkage of healthcare information residing in electronic health record (EHR) systems with information in clinical research information systems, such as clinical trials.

Find out more about Custodix here

Related Videos

Multiple Myeloma: evolving paradigm - Panel Discussion

Moderator: Dr Dibeyndu De/Panelists: Dr Amit Kumar, Dr Sunil Dharmani, Dr Siddharth Nanda AIIMS, Dr Avinash Tiwari, Dr Rudra Pratap, Dr Siddharth Turkar

Multiple Myeloma: evolving paradigm - Panel Discussion ( Moderator: Dr Dibeyndu De/Panelists: Dr Amit Kumar, Dr Sunil Dharmani, Dr Siddharth Nanda AIIMS, Dr Avinash Tiwari, Dr Rudra Pratap, Dr Siddharth Turkar )

Head & Neck - BMC Data

Dr Rashmi Rai / Dr Dipmalya Chatterjee - Balco Medical Center, Raipur, India

Head & Neck - BMC Data ( Dr Rashmi Rai / Dr Dipmalya Chatterjee - Balco Medical Center, Raipur, India )

Cancer mutation prediction using artificial intelligence

Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA

Cancer mutation prediction using artificial intelligence ( Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA )

Biomarkers, predictive and prognostic factors of resistance to immunotherapy

Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)/Clínica Universidad de Navarra, Spain

Biomarkers, predictive and prognostic factors of resistance to immunotherapy ( Dr Ignacio Gil-Bazo - Fundación Instituto Valenciano de Oncología (FIVO)/Clínica Universidad de Navarra, Spain )

GIST tumours and soft tissue sarcomas

Dr Atif Hussein - Memorial Cancer Institute, Miami, USA

GIST tumours and soft tissue sarcomas ( Dr Atif Hussein - Memorial Cancer Institute, Miami, USA )

Hormonal receptor positive breast cancer adjuvant and metastatic indications

Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA

Hormonal receptor positive breast cancer adjuvant and metastatic indications ( Dr Aurelio Castrellon - Memorial Cancer Institute, Miami, USA )

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

Relapsed refractory multiple myeloma

Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India

$Relapsed refractory multiple myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )$

Hope vs Hype of evidence interpretation

Dr Sanjoy Chatterjee - Tata Medical Center, Kolkata, India

Hope vs Hype of evidence interpretation ( Dr Sanjoy Chatterjee - Tata Medical Center, Kolkata, India )

More from ecancer